HEALTHY VOLUNTEERS - MALE AND FEMALE
Clinical trials for HEALTHY VOLUNTEERS - MALE AND FEMALE explained in plain language.
Never miss a new study
Get alerted when new HEALTHY VOLUNTEERS - MALE AND FEMALE trials appear
Sign up with your email to follow new studies for HEALTHY VOLUNTEERS - MALE AND FEMALE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Quinoa cookie trial: a tasty way to fight obesity?
Prevention CompletedThis study tested whether replacing some ingredients in cookies with quinoa could help healthy adults maintain normal blood fat and sugar levels, potentially lowering the risk of obesity and metabolic syndrome. Sixty healthy volunteers ate either a regular cookie or a quinoa-base…
Matched conditions: HEALTHY VOLUNTEERS - MALE AND FEMALE
Phase: NA • Sponsor: IMDEA Food • Aim: Prevention
Last updated Jun 27, 2026 12:01 UTC
-
Stomach acid drug may change how schizophrenia medication works
Knowledge-focused CompletedThis study looked at how a common stomach acid drug, pantoprazole, affects the levels of clozapine, a medication for schizophrenia. Thirty-three healthy volunteers took clozapine alone and again after several days of pantoprazole. Researchers measured drug concentrations in the b…
Matched conditions: HEALTHY VOLUNTEERS - MALE AND FEMALE
Phase: PHASE1 • Sponsor: Universiti Sains Malaysia • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:01 UTC
-
Can a natural supplement tweak your metabolism? new study tests OEA
Knowledge-focused CompletedThis completed study tested whether a single dose of oleoylethanolamide (OEA), a natural fat-like molecule, can change certain metabolic signals in the body. Forty healthy adults aged 30 and older with a BMI between 25 and 35 took either a placebo or OEA with LipiSperse (a formul…
Matched conditions: HEALTHY VOLUNTEERS - MALE AND FEMALE
Phase: PHASE4 • Sponsor: RDC Clinical Pty Ltd • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:57 UTC
-
New drug KP-001 put to the heart safety test
Knowledge-focused CompletedThis study checks whether a new drug called KP-001 affects the heart's electrical activity (QT interval) in 40 healthy adults. Participants receive single doses of KP-001, a placebo, or moxifloxacin (a control drug known to affect the QT interval) in random order. The goal is to …
Matched conditions: HEALTHY VOLUNTEERS - MALE AND FEMALE
Phase: PHASE1 • Sponsor: Kaken Pharmaceutical • Aim: Knowledge-focused
Last updated Jun 26, 2026 18:08 UTC